Clorazepate Dipotassium
NDC 63304-552
Product Information
Clorazepate Dipotassium is a ANDA-approved product labeled by Ranbaxy Pharmaceuticals Inc.. Clorazepate is used to treat anxiety, acute alcohol withdrawal, and seizures. It is supplied as a blue product. This product entry covers the primary NDC 63304-552 and 4 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
RX;552
Code Structure Chart
Product Details
What is NDC 63304-552?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CLORAZEPATE DIPOTASSIUM (UNII: 63FN7G03XY)
- CLORAZEPIC ACID (UNII: D51WO0G0L4) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- COLLOIDAL SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MAGNESIUM OXIDE (UNII: 3A3U0GI71G)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POTASSIUM CARBONATE (UNII: BQN1B9B9HA)
- POTASSIUM CHLORIDE (UNII: 660YQ98I10)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 197464 - clorazepate dipotassium 15 MG Oral Tablet
- RxCUI: 197465 - clorazepate dipotassium 3.75 MG Oral Tablet
- RxCUI: 197466 - clorazepate dipotassium 7.5 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.